CorMedix Inc. Insider Trading

CRMD

Last 12 months

Insiders sold $2.64M and bought nothing on the open market.

59% of the selling was scheduled in advance under 10b5-1 plans. Director Steven W Lefkowitz sold 475K on Dec 9, 2025, 26% of their stake, outside a plan. The last open-market buy by an executive or director was in Oct 2025.

Net open-market

−$2.64M

0 buys · 8 sales

Under a 10b5-1 plan

59%

of the value sold

Insiders who bought / sold

0 / 4

executives and directors

Last open-market buy

Oct 2025

Oct 23, 2025

Get an email when CRMD's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Jan 21	Janet Dillione Director	Sold10b5-1 plan	10,000	$6.88	69K	21%	Form 4
Dec 30, 2025	Alan W Dunton Director	Sold10b5-1 plan	20,000	$13.00	260K	33%	Form 4
Dec 18, 2025	Joseph Todisco Chief Executive Officer	Sold10b5-1 plan	30,000	$12.00	360K	5.6%	Form 4
Dec 9, 2025	Janet Dillione Director	Sold10b5-1 plan	34,000	$12.00	408K	41%	Form 4
Dec 9, 2025	Steven W Lefkowitz Director	SoldNo plan	40,000	$11.88	475K	26%	Form 4
Dec 2, 2025	Janet Dillione Director	Sold10b5-1 plan	46,657	$10.00	467K	49%	Form 4
Nov 24, 2025	Janet Dillione Director	SoldNo plan	26,343	$9.93	262K	35%	Form 4
Nov 14, 2025	Janet Dillione Director	SoldNo plan	30,000	$11.42	343K	38%	Form 4
Oct 23, 2025	Myron Kaplan Director	Bought	25,000	$11.02	276K	12%	Form 4
Sep 12, 2025	Alan W Dunton Director	SoldNo plan	10,000	$13.13	131K	20%	Form 4
Sep 12, 2025	Joseph Todisco Chief Executive Officer	SoldNo plan	50,000	$13.00	650K	8.9%	Form 4
Sep 9, 2025 – Sep 11, 2025	Elizabeth Hurlburt Chief Operating Officer	SoldNo plan 2 parts	53,997	$13.18 average	712K	23%	Form 4
Sep 9, 2025	Kaufman Beth Zelnick Chief Legal Officer	SoldNo plan 2 parts	50,000	$13.41 average	670K	22%	Form 4
Nov 14, 2024	Elizabeth Hurlburt EVP	SoldNo plan	140,027	$11.18	$1.57M	76%	Form 4

Jan 2110b5-1 plan
Janet Dillione
Director · sold 10,000 at $6.88
69K
21% of stake
Dec 30, 202510b5-1 plan
Alan W Dunton
Director · sold 20,000 at $13.00
260K
33% of stake
Dec 18, 202510b5-1 plan
Joseph Todisco
Chief Executive Officer · sold 30,000 at $12.00
360K
5.6% of stake
Dec 9, 202510b5-1 plan
Janet Dillione
Director · sold 34,000 at $12.00
408K
41% of stake
Dec 9, 2025No plan
Steven W Lefkowitz
Director · sold 40,000 at $11.88
475K
26% of stake
Dec 2, 202510b5-1 plan
Janet Dillione
Director · sold 46,657 at $10.00
467K
49% of stake
Nov 24, 2025No plan
Janet Dillione
Director · sold 26,343 at $9.93
262K
35% of stake
Nov 14, 2025No plan
Janet Dillione
Director · sold 30,000 at $11.42
343K
38% of stake
Oct 23, 2025
Myron Kaplan
Director · bought 25,000 at $11.02
276K
12% of stake
Sep 12, 2025No plan
Alan W Dunton
Director · sold 10,000 at $13.13
131K
20% of stake
Sep 12, 2025No plan
Joseph Todisco
Chief Executive Officer · sold 50,000 at $13.00
650K
8.9% of stake
Sep 9, 2025 – Sep 11, 2025No plan
Elizabeth Hurlburt
Chief Operating Officer · sold 53,997 at avg $13.18
712K
23% of stake
Sep 9, 2025No plan
Kaufman Beth Zelnick
Chief Legal Officer · sold 50,000 at avg $13.41
670K
22% of stake
Nov 14, 2024No plan
Elizabeth Hurlburt
EVP · sold 140,027 at $11.18
$1.57M
76% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch CRMD, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Pharmaceutical Preparations · Pick stocks to compare with CRMD

CompareIntrinsic value

ARQTArcutis Biotherapeutics Inc.

$34.05+6.41%65

ORGOOrganogenesis Holdings Inc.

$0.87+4.19%50

LQDALiquidia Corporation

$47.38+12.27%72

ARDXArdelyx Inc.

$3.27+7.92%40

ZLABZai Lab Ltd

$22.80+3.83%40

SVASernova Biotherapeutics Inc

No recent price0

INVAInnoviva Inc.

$21.26+1.58%56

NATRNature's Sunshine Products Inc.

$12.84+6.38%70

Held by ETFs

CRMD is in 25 US ETFs. The largest of them, with CRMD's weight in each:

Spot a number that looks wrong? Check it in CRMD's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing CRMD

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.